filings.toolsItem 1A. Risk Factors
3K characters. Original on sec.gov ·
Item 1A. Risk Factors
Certain factors may have a material adverse effect on our business, financial condition, results of operations and cash flows, and you should carefully consider them. It is not possible to predict or identify all such factors. For a discussion of potential risks or uncertainties affecting us, please refer to the information under the heading “Item 1A—Risk Factors” in our 2020 Annual Report. Additional risks and uncertainties that are not yet identified or that we currently believe to be immaterial may also materially harm our business, financial condition, results of operations and cash flows.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities:
| (In millions, except number of shares and per share amounts) | |||||||||||||||||||||||
| Period in 2021 | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs (1) | Approximate Dollar Value of Shares that May Yet be Purchased Under the Programs (1) | |||||||||||||||||||
| January 1 - January 31 | 95,000 | $ | 136.96 | 95,000 | $ | 773.5 | |||||||||||||||||
| February 1 - February 28 | 98,000 | 129.10 | 98,000 | 760.8 | |||||||||||||||||||
| March 1 - March 31 | 115,000 | 137.58 | 115,000 | 745.0 | |||||||||||||||||||
| April 1 - April 30 | 95,000 | 150.10 | 95,000 | 730.8 | |||||||||||||||||||
| May 1 - May 31 | 284,000 | 159.04 | 284,000 | 1,585.6 | |||||||||||||||||||
| June 1 - June 30 | 825,534 | 159.05 | 825,534 | 1,454.3 | |||||||||||||||||||
| July 1 - July 31 | 737,136 | 155.85 | 737,136 | 1,339.4 | |||||||||||||||||||
| August 1 - August 31 | 667,200 | 163.91 | 667,200 | 1,230.1 | |||||||||||||||||||
| September 1 - September 30 | 597,000 | 164.66 | 597,000 | 1,131.8 | |||||||||||||||||||
| Total | 3,513,870 | $ | 157.88 | 3,513,870 | $ | 1,131.8 |
(1)Shares purchased pursuant to the November 2018 and January 2021 publicly announced share repurchase authorizations of up to $600.0 million each of outstanding common stock. In May 2021, the Board authorized the repurchase of up to an additional $900.0 million aggregate cost at purchase of outstanding common stock. As of September 30, 2021, $1.13 billion aggregate cost at purchase remained unused under the existing January 2021 and May 2021 repurchase authorizations.
Previous: Item 1. Legal Proceedings · Next: Item 6. Exhibits